berotek has been researched along with Liver Neoplasms in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, RK | 1 |
| Ramamoorthy, A | 1 |
| Scheers, J | 1 |
| Wersto, RP | 1 |
| Toll, L | 1 |
| Jimenez, L | 1 |
| Bernier, M | 1 |
| Wainer, IW | 1 |
| Wilson, AA | 1 |
| Wang, J | 1 |
| Koch, P | 1 |
| Walle, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Study of (R, R') and (S,S': R,R')- Fenoterol: Initial Clinical Evaluation for Pharmacokinetics, Pharmacodynamics, and Safety[NCT01440335] | Phase 1 | 29 participants (Actual) | Interventional | 2011-07-10 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for berotek and Liver Neoplasms
| Article | Year |
|---|---|
Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Topics: Adrenergic beta-2 Receptor Agonists; Apoptosis; Carcinoma, Hepatocellular; Fenoterol; Hep G2 Cells; | 2012 |
Stereoselective sulphate conjugation of fenoterol by human phenolsulphotransferases.
Topics: Bronchodilator Agents; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Fenoterol; H | 1997 |